默沙东阿瑞匹坦是医保用药吗?
Merck received marketing authorization from the United States and the European Union in 2003. It is used in combination with other anti-vomiting drugs to prevent acute or delayed nausea and vomiting that occurs during initial or repeated chemotherapy for highly or moderately emetic tumors.
Merck's aprepitant blocks the effects of substance P by binding to NK-1 receptors (mainly found in the central nervous system and its periphery), and can pass through the blood-brain barrier and occupy NK-1 receptors in the brain. It has selectivity and high affinity, but has very low affinity for NK-2 and NK-3 receptors. At the same time, its affinity for the targets of other drugs used to treat chemotherapy-induced nausea and vomiting symptoms (such as dopamine receptors and 5-HT receptors) is also very low, and its effect in reducing nausea and vomiting is better than other drugs.
In addition to prescription drug business, Merck also includes animal health business in China. Nearly 50 veterinary products cover various fields such as disease prevention, treatment and control of livestock, poultry and pets, and are committed to protecting and caring for animal health and the health of humans who share weal and woe with them.
Is MSD aprepitant a medical insurance drug?
It is understood that it has not yet been included in medical insurance and is a self-paid drug for patients. Aprepitant is relatively expensive in China, and many patients use the version marketed abroad. If you need aprepitant, you can always consult Medical Companion Travel for relevant matters!
Recommended related hot articles: /newsDetail/96552.html
Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)